Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,291 active trials259 approved drugs3,814 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,377 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00881504 | A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma | terminated | Phase 2 | 9 | Georgetown UniversityOTHER | 1 | Oct 20, 2014 | clinicaltrials |
| NCT00482625 | Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | terminated | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | Oct 16, 2014 | clinicaltrials |
| NCT01653418 |
| Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation(V-BEAM) |
| terminated |
| Phase 2 |
| 10 |
| Washington University School of MedicineOTHER |
| 1 |
| Oct 15, 2014 |
| clinicaltrials |
| NCT01020305 | Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer | terminated | Phase 1 / Phase 2 | 5 | Sandy SrinivasOTHER | 1 | Oct 13, 2014 | clinicaltrials |
| NCT00390364 | Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy | terminated | Phase 2 | 1 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 8, 2014 | clinicaltrials |
| NCT00288067 | Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma | terminated | Phase 1 / Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Oct 6, 2014 | clinicaltrials |
| NCT01149434 | Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers | terminated | Phase 1 / Phase 2 | 19 | University of UtahOTHER | 1 | Oct 6, 2014 | clinicaltrials |
| NCT00072280 | Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma | terminated | Phase 2 | 7 | Children's Oncology GroupNETWORK | 4 | Sep 30, 2014 | clinicaltrials |
| NCT00982696 | Treatment of Advanced Head and Neck Cancer | terminated | Phase 2 | 5 | Milton S. Hershey Medical CenterOTHER | 1 | Sep 30, 2014 | clinicaltrials |
| NCT00910039 | Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases | terminated | Phase 2 | 14 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 29, 2014 | clinicaltrials |
| NCT01928615 | A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer(LISAH) | terminated | Phase 2 | 2 | Hoffmann-La RocheINDUSTRY | 1 | Sep 29, 2014 | clinicaltrials |
| NCT00642746 | Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC) | terminated | Phase 2 | 16 | OHSU Knight Cancer InstituteOTHER | 1 | Sep 26, 2014 | clinicaltrials |
| NCT02013765 | A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer | terminated | Phase 2 | 5 | Hoffmann-La RocheINDUSTRY | 1 | Sep 25, 2014 | clinicaltrials |
| NCT01272141 | A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer | terminated | Phase 2 | 5 | Emory UniversityOTHER | 1 | Sep 22, 2014 | clinicaltrials |
| NCT00675428 | Study of Natalizumab in Relapsed/Refractory Multiple Myeloma | terminated | Phase 1 / Phase 2 | 6 | BiogenINDUSTRY | 1 | Sep 19, 2014 | clinicaltrials |
| NCT01049776 | GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line | terminated | Phase 2 | 32 | Illinois CancerCare, P.C.OTHER | 1 | Sep 19, 2014 | clinicaltrials |
| NCT00570908 | Brain Mets - Capecitabine Plus Sunitinib and WBRT | terminated | Phase 2 | 12 | Baylor Breast Care CenterOTHER | 1 | Sep 18, 2014 | clinicaltrials |
| NCT01704027 | Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate Cancer | terminated | Phase 2 | 28 | Centre Georges Francois LeclercOTHER | 1 | Sep 18, 2014 | clinicaltrials |
| NCT00240162 | PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma | terminated | Phase 2 | 21 | Washington University School of MedicineOTHER | 1 | Sep 17, 2014 | clinicaltrials |
| NCT00634322 | High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma | terminated | Phase 2 | 7 | BTG International Inc.OTHER | 0 | Sep 15, 2014 | clinicaltrials |
| NCT02127372 | Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571 | terminated | Phase 1 / Phase 2 | 43 | Duke UniversityOTHER | 0 | Sep 15, 2014 | clinicaltrials |
| NCT00593645 | Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation | terminated | Phase 2 | 7 | Washington University School of MedicineOTHER | 1 | Sep 12, 2014 | clinicaltrials |
| NCT00723203 | Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | terminated | Phase 2 | 16 | City of Hope Medical CenterOTHER | 1 | Sep 9, 2014 | clinicaltrials |
| NCT01786226 | Mifepristone to Treat Uterine Fibroids | terminated | Phase 2 / Phase 3 | 220 | Mediterranea Medica S. L.OTHER | 1 | Sep 5, 2014 | clinicaltrials |
| NCT00691912 | Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin(MyoPac) | terminated | Phase 2 | 26 | Claudia Lorenz-SchlüterOTHER | 1 | Sep 3, 2014 | clinicaltrials |
| NCT00524459 | Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery | terminated | Phase 2 | 6 | Roswell Park Cancer InstituteOTHER | 1 | Aug 29, 2014 | clinicaltrials |
| NCT01305772 | Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN(TOP0901) | terminated | Phase 2 | 6 | Neal ReadyOTHER | 1 | Aug 29, 2014 | clinicaltrials |
| NCT02228785 | A Study of the Safety and Tolerance of Three Doses of G17DT in Metastatic Colorectal Cancer(CC1C) | terminated | Phase 2 | 5 | Cancer Advances Inc.INDUSTRY | 0 | Aug 29, 2014 | clinicaltrials |
| NCT00509366 | Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer(TOP0602) | terminated | Phase 2 | 101 | Duke UniversityOTHER | 1 | Aug 28, 2014 | clinicaltrials |
| NCT00538291 | Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment | terminated | Phase 2 | 13 | City of Hope Medical CenterOTHER | 1 | Aug 28, 2014 | clinicaltrials |
| NCT00544778 | Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma | terminated | Phase 2 | 7 | City of Hope Medical CenterOTHER | 0 | Aug 28, 2014 | clinicaltrials |
| NCT00225173 | Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease | terminated | Phase 2 | 45 | Stanford UniversityOTHER | 1 | Aug 27, 2014 | clinicaltrials |
| NCT01365910 | Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer | terminated | Phase 2 | 30 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 26, 2014 | clinicaltrials |
| NCT00958893 | An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext | terminated | Phase 2 | 4 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 25, 2014 | clinicaltrials |
| NCT00470067 | Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer | terminated | Phase 2 | 9 | Roswell Park Cancer InstituteOTHER | 1 | Aug 22, 2014 | clinicaltrials |
| NCT01682031 | Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy | terminated | Phase 2 | 18 | Roswell Park Cancer InstituteOTHER | 2 | Aug 22, 2014 | clinicaltrials |
| NCT00683917 | Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 2 | 10 | Repros Therapeutics Inc.INDUSTRY | 2 | Aug 21, 2014 | clinicaltrials |
| NCT00385827 | A Safety and Efficacy Study of Siltuximab (CNTO 328) in Male Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC) | terminated | Phase 2 | 106 | Centocor, Inc.INDUSTRY | 7 | Aug 20, 2014 | clinicaltrials |
| NCT01403259 | SOX as Salvage Treatment in Nasopharyngeal Carcinoma | terminated | Phase 2 | 16 | Fudan UniversityOTHER | 1 | Aug 20, 2014 | clinicaltrials |
| NCT01914718 | Dose-adjusted EPOCH-R in MYC Positive DLBCL | terminated | Phase 2 | 26 | Fudan UniversityOTHER | 1 | Aug 20, 2014 | clinicaltrials |
| NCT00265915 | Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic Leukemia | terminated | Phase 2 | — | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 0 | Aug 12, 2014 | clinicaltrials |
| NCT01430585 | Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer | terminated | Phase 2 | 14 | PfizerINDUSTRY | 4 | Aug 12, 2014 | clinicaltrials |
| NCT00576901 | A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer. | terminated | Phase 2 | 23 | Hoffmann-La RocheINDUSTRY | 1 | Aug 11, 2014 | clinicaltrials |
| NCT01363986 | A Study of Herceptin (Trastuzumab) in Combination With Whole Brain Radiotherapy in Patients With HER-2 Positive Breast Cancer | terminated | Phase 2 | 3 | Hoffmann-La RocheINDUSTRY | 1 | Aug 11, 2014 | clinicaltrials |
| NCT02005484 | A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression | terminated | Phase 2 | 6 | Hoffmann-La RocheINDUSTRY | 2 | Aug 11, 2014 | clinicaltrials |
| NCT00517699 | A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma. | terminated | Phase 2 | 5 | Hoffmann-La RocheINDUSTRY | 1 | Aug 8, 2014 | clinicaltrials |
| NCT01189253 | Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma | terminated | Phase 2 / Phase 3 | 133 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Aug 8, 2014 | clinicaltrials |
| NCT01276054 | Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients. | terminated | Phase 2 | 4 | University of Southern CaliforniaOTHER | 1 | Aug 1, 2014 | clinicaltrials |
| NCT01397591 | Ofatumumab and Bortezomib in Subjects With Relapsed CD20+Diffuse Large B Cell, Follicular, or Mantle Cell Lymphoma | terminated | Phase 2 | 3 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 30, 2014 | clinicaltrials |
| NCT02204332 | Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment(COMETA) | terminated | Phase 2 | 38 | Hospital Clinico Universitario de SantiagoOTHER | 1 | Jul 30, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Oct 20, 2014source: clinicaltrials